Ron Cohen | Founder, President and CEO |
Mike Gesser | CFO |
Tierney Saccavino | EVP, Corporate Communications |
Muzamil Saleem | H.C. Wainwright |
Good afternoon. Welcome to Acorda Therapeutics First Quarter 2022 Financial and Business Update. Please be advised that this call is being recorded at the company's request. I will now introduce you to our host, Tierney Saccavino, Acorda's Communications Consultant. Tierney, please go ahead.